Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway

Derek B. Oien, Jeremy Chien, Nikki Cheng

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The primary chemotherapeutic agents for epithelial ovarian cancer are platinum-based drugs, which are commonly used in combination with a taxane regimen. These treatments are generally effective at achieving remission, but the remission is often followed by a relapse and acquired resistance to chemotherapy. In order to overcome these barriers of drug resistance, it is important to understand the underlying mechanisms regulating the development of drug-resistant tumors. Tumors evolve through interactions with the surrounding microenvironment, which are comprised of a complex mixture of cells including fibroblasts and immune cells. In ovarian cancer, fibroblasts can make up a significant component of the primary tumor. While fibroblasts are known to influence the behavior of cancer cells directly through secretion of growth factors, and extracellular matrix (ECM) proteins, the interactions between fibroblasts and immune cells are less understood. In a recently published study from Cell, Wang and colleagues present intriguing work characterizing the role of fibroblast and T cells in modulating platinum resistance in ovarian cancer. Here, we briefly summarize and comment on their findings in relation to the tumor microenvironment and chemoresistance.

Original languageEnglish (US)
Pages (from-to)S514-S519
JournalTranslational Cancer Research
Volume5
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Glutathione
Fibroblasts
Platinum
Neoplasms
Tumor Microenvironment
Extracellular Matrix Proteins
Complex Mixtures
Drug Resistance
Pharmaceutical Preparations
Intercellular Signaling Peptides and Proteins
T-Lymphocytes
Recurrence
Drug Therapy
Therapeutics

Keywords

  • Chemo-resistance
  • Effector T cell
  • Fibroblasts
  • Ovarian cancer
  • Platinum

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway. / Oien, Derek B.; Chien, Jeremy; Cheng, Nikki.

In: Translational Cancer Research, Vol. 5, 01.01.2016, p. S514-S519.

Research output: Contribution to journalArticle

@article{aff74c69084e4b7aac4a046bae967308,
title = "Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway",
abstract = "The primary chemotherapeutic agents for epithelial ovarian cancer are platinum-based drugs, which are commonly used in combination with a taxane regimen. These treatments are generally effective at achieving remission, but the remission is often followed by a relapse and acquired resistance to chemotherapy. In order to overcome these barriers of drug resistance, it is important to understand the underlying mechanisms regulating the development of drug-resistant tumors. Tumors evolve through interactions with the surrounding microenvironment, which are comprised of a complex mixture of cells including fibroblasts and immune cells. In ovarian cancer, fibroblasts can make up a significant component of the primary tumor. While fibroblasts are known to influence the behavior of cancer cells directly through secretion of growth factors, and extracellular matrix (ECM) proteins, the interactions between fibroblasts and immune cells are less understood. In a recently published study from Cell, Wang and colleagues present intriguing work characterizing the role of fibroblast and T cells in modulating platinum resistance in ovarian cancer. Here, we briefly summarize and comment on their findings in relation to the tumor microenvironment and chemoresistance.",
keywords = "Chemo-resistance, Effector T cell, Fibroblasts, Ovarian cancer, Platinum",
author = "Oien, {Derek B.} and Jeremy Chien and Nikki Cheng",
year = "2016",
month = "1",
day = "1",
doi = "10.21037/tcr.2016.09.32",
language = "English (US)",
volume = "5",
pages = "S514--S519",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway

AU - Oien, Derek B.

AU - Chien, Jeremy

AU - Cheng, Nikki

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The primary chemotherapeutic agents for epithelial ovarian cancer are platinum-based drugs, which are commonly used in combination with a taxane regimen. These treatments are generally effective at achieving remission, but the remission is often followed by a relapse and acquired resistance to chemotherapy. In order to overcome these barriers of drug resistance, it is important to understand the underlying mechanisms regulating the development of drug-resistant tumors. Tumors evolve through interactions with the surrounding microenvironment, which are comprised of a complex mixture of cells including fibroblasts and immune cells. In ovarian cancer, fibroblasts can make up a significant component of the primary tumor. While fibroblasts are known to influence the behavior of cancer cells directly through secretion of growth factors, and extracellular matrix (ECM) proteins, the interactions between fibroblasts and immune cells are less understood. In a recently published study from Cell, Wang and colleagues present intriguing work characterizing the role of fibroblast and T cells in modulating platinum resistance in ovarian cancer. Here, we briefly summarize and comment on their findings in relation to the tumor microenvironment and chemoresistance.

AB - The primary chemotherapeutic agents for epithelial ovarian cancer are platinum-based drugs, which are commonly used in combination with a taxane regimen. These treatments are generally effective at achieving remission, but the remission is often followed by a relapse and acquired resistance to chemotherapy. In order to overcome these barriers of drug resistance, it is important to understand the underlying mechanisms regulating the development of drug-resistant tumors. Tumors evolve through interactions with the surrounding microenvironment, which are comprised of a complex mixture of cells including fibroblasts and immune cells. In ovarian cancer, fibroblasts can make up a significant component of the primary tumor. While fibroblasts are known to influence the behavior of cancer cells directly through secretion of growth factors, and extracellular matrix (ECM) proteins, the interactions between fibroblasts and immune cells are less understood. In a recently published study from Cell, Wang and colleagues present intriguing work characterizing the role of fibroblast and T cells in modulating platinum resistance in ovarian cancer. Here, we briefly summarize and comment on their findings in relation to the tumor microenvironment and chemoresistance.

KW - Chemo-resistance

KW - Effector T cell

KW - Fibroblasts

KW - Ovarian cancer

KW - Platinum

UR - http://www.scopus.com/inward/record.url?scp=84992061397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992061397&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.09.32

DO - 10.21037/tcr.2016.09.32

M3 - Article

AN - SCOPUS:84992061397

VL - 5

SP - S514-S519

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -